Korean Journal of Poultry Science (한국가금학회지)

The Korean Society of Poultry Science (한국가금학회)
권호 표지

Evaluation on Immunogenicity and Safety of Avian Influenza Isolate(ADL0401) as a Candidate for the Killed Vaccine against tow-Pathogenic Avian Influenza

약병원성 조류인플루엔자 사독백신개발을 위한 후보주(ADL0401)의 면역 원성 및 안전성 평가

  • Lee J. S. (College of Veterinary Medicine, Chungbuk National University) ;
  • Ha D. H. (College of Veterinary Medicine, Chungbuk National University) ;
  • Kim J. E. (College of Veterinary Medicine, Chungbuk National University) ;
  • Ha B. D. (College of Veterinary Medicine, Chungbuk National University) ;
  • Mo I. P. (College of Veterinary Medicine, Chungbuk National University)
  • Published : 2005.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

Avian influenza (AI) virus (AIV) is distributed worldwide and it has been isolated from various species of wild and domestic birds. AI transfers with high speed and shows diverse pathogenicity syndroms. In Korea, several low Pathogenic AIV, H9N2, have been isolated from the commercial farms with severe decrease of egg production and mortality resulted in severe economic loss since 1996. Therefore, it has been requested to develop AI vaccines to prevent clinical signs and economic losses from the field infection of AIV. To develop a killed vaccine that efficiently prevents low pathogenic AIV (H9N2), evaluation on the pathogenicity and selection of an inactivator for H9N2 is taking place and is being tested safety and immunogenicity of vaccine produced. Based on the pathogenicity test and viral reisolation test, the ADL0401 isolate is the characteristic low pathogenic AIVs and has fairly similar biologic functions compared with MS96 which is the official low pathogenic AIV (H9N2) and one of the predominant AIV isolated from poultry farms in Korea. In antigenicity tests, the ADL0401 and MS96 virus have no significant antigenic difference. In inactivation tests, the ADL0401 isolates can be easily inactivated with $0.1\%$ Formalin at $37^{\circ}C$ within 1 hour with a little decrease of HA titer. The vaccine developed in the present report has no harmful effect on bird and forms good immune capability. Therefore, the isolates, ADL0401 can be used for a killed vaccine which can reduce the clinical signs and viral shedding in the birds infected with H9N2 low pathogenic AIVs.

본 연구는 약병원성 조류인플루엔자 사독백신 개발을 위하여 백신 후보주(ADL0401)로서의 생물학적 특성 및 개발 백신에 대한 면역원성 및 안전성 평가를 실시하였다. 백신 후보주인 ADL0401의 병원성을 조사한 결과 폐사는 없었으며, 임상증상 및 바이러스 재분리율 양상이 국내 표준 야외주인 MS96과 상당히 유사한 생물학적 특성을 나타내어 약병원성 조류인플루엔자의 특징을 갖고 있음을 알 수 있었다. 표준야외주인 MS96과 백신후보주인 ADL0401간의 이종항원의 중화능 실험을 한 결과 r값 = 0.71로 동종항원(r값 = 1)에 비하여 다소 낮은 중화능을 나타내었지만, 두 바이러스간의 항원성엔 큰 차이가 없음을 알 수 있었다. 불활화 능력실험으로 $0.1\%$ Formalin을 $37^{\circ}C$ 조건에서 처리하였을 때 가장 효과적인 결과를 가져왔으며, MS96은 2시간, ADL0401은 1시간만에 다소의 역가 저하는 있었으나 빠르게 불활화가 이루어짐을 확인하였다. 개발 백신의 면역원성 및 안전성 실험 결과 ISA 70 adjuvant 백신 접종시 백신 접종 전후로 폐사율 및 임상증상은 관찰되지 않았으며, 높은 수준의 항체 역가를 형성함으로써 가장 면역원성이 우수한 것으로 확인되었다.

Keywords

References

  1. Alexander DJ, Gough RE 1986 Isolations of avian influenza virus from birds in Great Britain. Vet Rec 118:537-538 https://doi.org/10.1136/vr.118.19.537
  2. Archetti I, Horsfall FL 1950 Persistent antigenic variation of influenza A viruses after incomplete neutralization in ova with heterologous immune serum. J Exp .Med 92:441-462 https://doi.org/10.1084/jem.92.5.441
  3. Bano S, Naeem K, Malik SA 2003 Evaluation of pathogenic potential of avian influenza virus serotype H9N2 in chickens. Avian Dis 47:817-822 https://doi.org/10.1637/0005-2086-47.s3.817
  4. Barr PJ 1991 Mammalian Subtilisins : The longsought dibasic processing endoproteases. Cell 66(1): 1-3 https://doi.org/10.1016/0092-8674(91)90129-M
  5. Cadman HF, Kelly PJ, Zhou R, Davelaar F, Mason PR 1994 A broad-spectnnn avian influenza subtype antigen for indirect enzyme-linked immunosorbent assay for antibodies against poultry pathogens in ostriches (Struthio camelus) from Zimbabwe. Avian Dis 38:621-625 https://doi.org/10.2307/1592088
  6. Cooley AJ, Campen GV, Philpott MS, Easterday BC, Hinshaw VS 1989. Pathological lesions in the lungs of ducks infected with influenza A viruses. Vet Pathol 26:1-5 https://doi.org/10.1177/030098588902600101
  7. David ES, Joan RB, Michael LP, Charles WB 2001 Efficasyof vaccine in chickens against highly pathogenic Hong Kong HSN1 avian influenza. Avian Dis 45:355-365 https://doi.org/10.2307/1592975
  8. Easterday BC, Hinshaw VS, Halvorson DA 1997 Influenza. In : Diseases of Poultry, 10th ed. Calnek BW, Barnes HJ, Beard CW, Mcdougald LR, Saif YM, eds. Iowa State University Press Ames IA, pp. 583-605
  9. Guan Y, Shortridge KF, Krauss S, Webster RG 1999 Molecularcharacterization of H9N2 influenza viruses : were they the donors of the 'internal' genes of HSNI viruses in Hong Kong? Proc Natl Acad Sci USA 96:9363-9367 https://doi.org/10.1073/pnas.96.16.9363
  10. Guo YJ, Krauss S, Senne DA 2000 Characterization of the pathogenicity of members of the newly established H9N2 influenza virus lineages in Asia. Virology 267:279-288 https://doi.org/10.1006/viro.1999.0115
  11. Horimoto T, Nakayama K, Smeekens SP, Kawaoka Y 1994 Proprotein-processing endoproteases PC6 and furin both activate hemagglutinin of virulent avian influenza viruses. J Virol 68(9):6074-6078
  12. Hurst A 1957 Approaches to the chemotherapy of virus diseases. J Pharm Pharmacol 9:273-292 https://doi.org/10.1111/j.2042-7158.1957.tb12281.x
  13. Kawaoka Y, Webster RG 1988 Sequence requirement for cleavage activation of influenza virus hemagglutinin expressed in mammalian cells. Proc Natl Acad Sci USA 85: 324-328 https://doi.org/10.1073/pnas.85.2.324
  14. Kilbourne ED 1975 The influenza viruses and infection. An introduction. In : Kilbourne ED ed. The influenza viruses and influenza. Academic Press New York, pp 1-4
  15. Krug RM, Lamb RA 2001 Orthomyxoviridae: The viruses and their replication. In: Field virology, 4th ed. Knipeand DM, Howlet PM, eds. Lippincott Williams and Wildins. Chapter 46, pp 1487-1532
  16. Lamb RA 1990 Orthomyxoviruses. In : Virology, Field BN, ed. Raven Press New York, pp 1091-1152
  17. Lee CW, S CS, L YJ, M IP 2000 Sequence analysis of the hemagglutinin gene of H9N2 Korean avian influenza viruses and assessment of the pathogenic potential of isolate MS96. Avian Dis 44:527-535 https://doi.org/10.2307/1593091
  18. Liu M, Guan Y, Peiris M, He S, Webby RJ, Perez D, Webster RG 2003 The quest of influenza a viruses for new hosts. Avian Dis 47(3):849-856 https://doi.org/10.1637/0005-2086-47.s3.849
  19. Magill TP, Fransis T 1936 Jr Proc Soc Exp Biol and Med. 35:463
  20. Marandi MY, Bozorgmehrifard MH, Hashemzadeh M 1999 Efficacy of inactivated H9N2 avian influenza vaccine against non-highly pathogenic A/Chicken/Iran/ ZMT-101/98 infection
  21. Nili H, Asasi K 2003 Avian influenza(H9N2) outbreak in Iran. Avian Dis 47:828-831 https://doi.org/10.1637/0005-2086-47.s3.828
  22. Palese P, Young JF 1982 Variation of influenza A, B, and C viruses. Science 215 :1468-1474 https://doi.org/10.1126/science.7038875
  23. Panigrahy B, Senne DA, Pearson JE 1995 Presence of avian influenza virus (AN) subtypes H5N2 and H7N1 in emus (Dromaius novaehollandiae) and rheas (Rhea americana) : Virus isolation and serologic findings. Avian Dis 39:64-67 https://doi.org/10.2307/1591983
  24. Parsons GD, Alexander J, Manwell RJ 1986 Experimental assessment of the pathogenicity of eight influenza A viruses of N5 subtype for chickens, turkeys, ducks and quail. Avian Pathol 15:647-662 https://doi.org/10.1080/03079458608436328
  25. Skeeles JK, Beasley JN, Blore P, Klopp S 1981 Severe egg-production drops in turkey breeders in Southcentral Missouri. Avian Dis 25:764-767 https://doi.org/10.2307/1590012
  26. Shortridge KF, Zhou NN, Guan Y, Gao P, Ito T, Kawaoka Y, Kodihalli S, Krauss S, Markwell D, Murti KG, Norwood M, Senne D. Sims L. Takada A Webster RG 1998 Characterization of avian H5N1 influenza viruses from poultry in Hong Kong. Virology 252:331-342 https://doi.org/10.1006/viro.1998.9488
  27. Stieneke-Grober A, Vey M, Ang1iker H, Shaw E, Thomas G, Robert C, Klenk lID, Garten W 1992 Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J 11(7):2407-2414
  28. Suarez DL, Senne DA 2000 Sequence analysis of related 10wpathogenic and highly pathogenic H5N2 avian influenza isolates from United States live bird markets and poultry farms from 1983 to 1989. Avian Dis 44:356-364 https://doi.org/10.2307/1592550
  29. Tumpey TM, Suarez DL, Perkins LEL, Senne DA, Lee J, Lee YJ, Mo IP, Sung HW, Swayne DE 2003 Evaluation of a high-pahogenicity H5N1 avian influenza A virus isolated from duck meat. Avian Dis 47:951-955 https://doi.org/10.1637/0005-2086-47.s3.951
  30. Vey M, Orlich M, Adler S, Klenk GD, Rott R, Garten W 1992 Hemagglutinin activation of pathogenic avian influenza viruses of serotype H7 requires the protease recognition Motif R-X-K/R-R. Virology 188:408-413 https://doi.org/10.1016/0042-6822(92)90775-K
  31. Walker JA, Sakaguchi T, Matsuda Y, Yoshida T, Kawaoka Y 1992 Location and character of the cellular enzyme that cleavage the hemagglutinin of a virulent avian influenza virus. Virology 190(1):278-287 https://doi.org/10.1016/0042-6822(92)91214-F
  32. Woolcock MD, McFarland MD, Lai S, Chin RP 2001 Enhanced recovery of avian influenza virus isolates by a combination of chicken embryo inoculation methods. Avian Dis 45: 1030-1035 https://doi.org/10.2307/1592884
  33. World Health Organization Report 1973 Influenza neuraminidase and neuraminidase-inhibition test procedures. Bull WHO 48:199-203
  34. Xie Z, Stone HD 1990 Immune response to oil-emulsion vaccines with single or mixed antigens of newcastle disease, avian influenza and infectious bronchitis. Avian Dis 31: 154-162
  35. 성환우 2003 공중보건 위생측면에서의 조류 인플루엔자 바 이러스 및 최근 국내 유행주의 특성.2003년 가금질병연구회 학술세미나, pp. 5-16